Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives

18 Feb 2023 · Jane Lowe
Getting started with ESG
In recent years, there has been a growing trend among investors to incorporate environmental, social, and governance (ESG) factors into their investment decisions. As a result, it has become increasin...
Read article
08 Feb 2023 · Paul Langley
BioSpectrum Asia’s 23 Life Science trends to watch in 2023
BioSpectrum Asia recently published an article titled “23 Life Sciences trends to watch in 2023”, where a range of industry experts provided their predictions.
Read article
09 Nov 2022 · Paul Langley
IR Department’s Managing Director honoured at Women in Finance Awards 2022
An elated Jane took to the stage to accept her award at The Star in Sydney on 3 November 2022, to thank the Boards and Directors from the small cap businesses she works with, for the opportunity to wo...
Read article
31 Oct 2022 · Paul Langley
IR Department Managing Director Jane Lowe featured in CFO magazine
IR Department is proud to share this CFO Magazine feature article on Managing Director Jane Lowe, where she shares some insights on the importance of the CFO’s role in investor relations. The article…
Read article
11 Oct 2022 · Paul Langley
IR Department Managing Director: Award Finalist
We are so excited to announce that the IR Department’s Managing Director, Jane Lowe, has been shortlisted as a finalist in the Women in Finance Awards 2022 – Small Business Adviser category. The…
Read article
13 Sep 2022 · Paul Langley
Podcast - interview with Peter Devine, CEO of Uniseed
Interview with Peter Devine, CEO of Uniseed
Read article
31 Aug 2022 · Cherie Hartley
IR Department client media highlights
IR Department client media highlights:
Read article
31 Aug 2022 · Paul Langley
Interview with Peter Devine, CEO of Uniseed
We talk with Peter Devine, CEO of Uniseed, about the current ESG landscape, ethical investing, their recent partnership with UniSuper and his surprising leisure activity.
Read article
29 Aug 2022 · Paul Langley
XPON CEO Matt Forman discusses Wondaris and how it integrates with Google
XPON's Founder and Group CEO Matt Forman explains the ground-breaking technology behind Wondaris and how it is changing the landscape of digital data recording.
Read article
29 Aug 2022 · Paul Langley
Race Oncology CSO Dr Daniel Tillett discusses the bright future for Zantrene
We speak with Dr Daniel Tillett, Chief Scientific Officer of Race Oncology, about the potential market and efficacy of their drug, Zantrene, which seems likely to change the cancer treatment landscape...
Read article